3D Systems announced FDA approval for a groundbreaking 3D-printed bioabsorbable medical device, COAPTIUM® CONNECT with TISSIUM Light, designed for the repair of peripheral nerve damage. This ...

The acquisition will enable Stryker to expand its portfolio with intravascular lithotripsy technology from Amplitude Vascular ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

Stryker (NYSE:SYK), a global leader in medical technologies, announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology ...

ROCK HILL, South Carolina, June 26, 2025 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE: DDD) announced that its 3D bioprinting technologies have enabled FDA approval for the regenerative repair of ...

– Provides interventionalists with optimal product choices for more complex radial-to-peripheral procedures – SOMERSET, N.J., Dec. 3, 2024 /PRNewswire/ -- Terumo Interventional Systems (TIS), a ...

Others, however, believed that the peripheral nervous system (nerves that connect the body's extremities to the brain) played a larger role, as nerves in the moving limbs produced feedback signals ...

Collaboration with French MedTech company, TISSIUM, has resulted in FDA approval for unique 3D-printed polymeric solution for repair of peripheral nerve damage 3D Systems’ bioprinting system enabled ...

Stryker announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), which is a private ...

Amplitude’s intravascular lithotripsy technology could emerge as a challenger to Shockwave IVL, Leerink Partners analyst Mike ...